DMPK and myotonic dystrophy type 2: However, the use of appropriate cellular models of DM1 and DM2 for different ceRNA crosstalk investigations is considerably limited due to the neuromuscular nature of these diseases, low levels of DMPK and CNBP/ZNF9 transcripts in affected cells [97,143,144] and genetic background variation [145].